These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9927189)

  • 1. The community effect in FGF-1 mediated tumor progression of a rat bladder carcinoma does not involve a direct paracrine signaling.
    Jouanneau J; Moens G; Thiery JP
    Oncogene; 1999 Jan; 18(2):327-33. PubMed ID: 9927189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo.
    Jouanneau J; Plouet J; Moens G; Thiery JP
    Oncogene; 1997 Feb; 14(6):671-6. PubMed ID: 9038374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2.
    Billottet C; Janji B; Thiery JP; Jouanneau J
    Oncogene; 2002 Nov; 21(53):8128-39. PubMed ID: 12444548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear 24 kD fibroblast growth factor (FGF)-2 confers metastatic properties on rat bladder carcinoma cells.
    Okada-Ban M; Moens G; Thiery JP; Jouanneau J
    Oncogene; 1999 Nov; 18(48):6719-24. PubMed ID: 10597279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact on tumor angiogenesis and tumor progression of expression of the 18 kd and 24 kd isoforms of FGF-2].
    Okada-Ban M; Grassi M; Plouet J; Thiery JP; Jouanneau J
    Pathol Biol (Paris); 1999 Apr; 47(4):375-9. PubMed ID: 10372408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct FGF receptor 1 activation through an anti-idiotypic strategy mimicks the biological activity of FGF-2 and inhibits the progression of the bladder carcinoma derived from NBT-II cells.
    Malavaud B; Pedron S; Sordello S; Mazerolles C; Billottet C; Thiery JP; Jouanneau J; Plouët J
    Oncogene; 2004 Sep; 23(40):6769-78. PubMed ID: 15273729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SFL production by carcinoma cells induces the aggressive properties of nonproducing cells in vivo via a community effect.
    Bellusci S; Moens G; Delouvée A; Thiery JP; Jouanneau J
    Invasion Metastasis; 1994-1995; 14(1-6):319-28. PubMed ID: 7657525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.
    Chaffer CL; Dopheide B; Savagner P; Thompson EW; Williams ED
    Differentiation; 2007 Nov; 75(9):831-42. PubMed ID: 17697126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular aspects of invasiveness and metastasis].
    Jouanneau J; Bellusci S; Moens G; Thiery JP
    Pathol Biol (Paris); 1995 Mar; 43(3):181-7. PubMed ID: 7545809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NBT-II carcinoma behaviour is not dependent on cell-cell communication through gap junctions.
    Lesueur F; Mesnil M; Delouvée A; Girault JM; Yamasaki H; Thiery JP; Jouanneau J
    Biochem Biophys Res Commun; 2002 May; 294(1):108-15. PubMed ID: 12054748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of scatter/growth factors in tumor progression.
    Boyer B; Vallés AM; Jouanneau J; Delouvée A; Thiery JP
    Princess Takamatsu Symp; 1994; 24():233-42. PubMed ID: 8983078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BALB/c 3T3 cells co-expressing FGF-2 and soluble FGF receptor acquire tumorigenicity.
    Seno M; Masago A; Nishimura A; Tada H; Kosaka M; Sasada R; Igarashi K; Seno S; Yamada H
    Cytokine; 1998 Apr; 10(4):290-4. PubMed ID: 9617574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
    Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
    Liu TC; Zhang T; Fukuhara H; Kuroda T; Todo T; Canron X; Bikfalvi A; Martuza RL; Kurtz A; Rabkin SD
    Clin Cancer Res; 2006 Nov; 12(22):6791-9. PubMed ID: 17121900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
    Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
    Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells.
    Bansal R; Magge S; Winkler S
    J Neurosci Res; 2003 Nov; 74(4):486-93. PubMed ID: 14598292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear FGF-2 facilitates cell survival in vitro and during establishment of metastases.
    Thomas-Mudge RJ; Okada-Ban M; Vandenbroucke F; Vincent-Salomon A; Girault JM; Thiery JP; Jouanneau J
    Oncogene; 2004 Jun; 23(27):4771-9. PubMed ID: 15122340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of several waves of gene expression during FGF-1 induced epithelial-mesenchymal transition of carcinoma cells.
    Billottet C; Tuefferd M; Gentien D; Rapinat A; Thiery JP; Broët P; Jouanneau J
    J Cell Biochem; 2008 Jun; 104(3):826-39. PubMed ID: 18189245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.